Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.

MLA

Schulz, S.Charles, et al. “Olanzapine for the Treatment of Borderline Personality Disorder: Variable Dose 12-Week Randomised Double-Blind Placebo-Controlled Study.” The British Journal of Psychiatry : The Journal of Mental Science, vol. 193, no. 6, Dec. 2008, pp. 485–92. EBSCOhost, https://doi.org/10.1192/bjp.bp.107.037903.

APA

Schulz, S. C., Zanarini, M. C., Bateman, A., Bohus, M., Detke, H. C., Trzaskoma, Q., Tanaka, Y., Lin, D., Deberdt, W., & Corya, S. (2008). Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. The British Journal of Psychiatry : The Journal of Mental Science, 193(6), 485–492. https://doi.org/10.1192/bjp.bp.107.037903

Chicago

Schulz, S Charles, Mary C Zanarini, Anthony Bateman, Martin Bohus, Holland C Detke, Quynh Trzaskoma, Yoko Tanaka, Daniel Lin, Walter Deberdt, and Sara Corya. 2008. “Olanzapine for the Treatment of Borderline Personality Disorder: Variable Dose 12-Week Randomised Double-Blind Placebo-Controlled Study.” The British Journal of Psychiatry : The Journal of Mental Science 193 (6): 485–92. doi:10.1192/bjp.bp.107.037903.